Biopreservation Equipment Market Size, Share, Growth, and Industry Analysis, By Type (Temperature Control Systems,Incubators,Centrifuges,Alarms & Monitoring Systems,Accessories,Others), By Application (Therapeutic Applications,Research Applications,Clinical Trials,Others), Regional Insights and Forecast to 2035

Biopreservation Equipment Market Overview

Global Biopreservation Equipment Market size is projected at USD 882.14 million in 2026 and is anticipated to reach USD 1127.97 million by 2035, registering a CAGR of 2.8%.

The biopreservation equipment market is driven by the increasing need to store biological samples at controlled temperatures, with over 65% of global laboratories relying on advanced preservation systems in 2024. Approximately 72% of biobanks utilize ultra-low temperature freezers operating below −150°C for long-term storage. The adoption of automated monitoring systems has increased by 48% across research facilities, ensuring sample integrity. Cryogenic storage solutions account for nearly 38% of total equipment usage globally. Additionally, over 55% of pharmaceutical companies have integrated biopreservation systems into drug development workflows, highlighting the growing dependence on controlled storage technologies across biotechnology, clinical research, and regenerative medicine sectors.

The United States represents a highly advanced segment, with nearly 68% of research institutions using automated biopreservation systems as of 2024. Around 59% of clinical laboratories employ liquid nitrogen-based storage systems for cell therapies. The country hosts over 400 biobanks, storing more than 20 million biological samples. Approximately 63% of pharmaceutical companies in the U.S. rely on temperature-controlled preservation equipment for biologics. Adoption of real-time monitoring systems has reached 52% across laboratories, ensuring compliance with regulatory standards. Furthermore, around 47% of stem cell research facilities depend on cryopreservation systems to maintain sample viability over extended periods.

Download FREE Sample to learn more about this report.

Key Findings

• Key Market Driver: Increasing biologics demand contributes 64% growth, while 57% expansion in stem cell therapies and 52% rise in vaccine storage requirements accelerate equipment adoption globally.
• Major Market Restraint: High installation costs impact 48% of facilities, while 42% face energy consumption issues and 36% encounter maintenance-related limitations affecting equipment upgrades.
• Emerging Trends: Smart storage systems adoption has reached 53%, while AI-based monitoring stands at 46% and remote access technologies account for 41% implementation across laboratories.
• Regional Leadership: North America leads with 42%, Europe follows with 30%, Asia-Pacific holds 21%, and Middle East & Africa contribute 7% to overall market distribution.
• Competitive Landscape: Leading players control 60% share, mid-level companies hold 25%, and small-scale manufacturers contribute 15% to the global competitive structure.
• Market Segmentation: Temperature systems account for 37%, incubators hold 19%, centrifuges represent 13%, monitoring systems cover 11%, and accessories plus others contribute 20% combined.
• Recent Development: Product innovation increased by 45%, automation integration reached 40%, and IoT-based solutions adoption grew to 35% across newly launched systems.

Biopreservation Equipment Market Latest Trends

The market is witnessing a strong shift toward automation, with 51% of laboratories adopting automated storage systems to reduce human error and improve efficiency. Approximately 44% of facilities now use cloud-based monitoring systems, allowing real-time tracking of temperature and storage conditions. The integration of IoT-enabled devices has increased by 37%, enhancing predictive maintenance and reducing equipment downtime by 28%. Cryogenic preservation techniques have gained traction, with 42% of research institutions

utilizing liquid nitrogen storage for long-term sample viability. Energy-efficient equipment adoption has risen by 39%, addressing concerns about high power consumption associated with ultra-low temperature freezers. Additionally, around 33% of manufacturers are focusing on compact equipment designs to optimize laboratory space utilization. The use of AI-driven analytics in preservation systems has increased by 29%, enabling better sample management and risk assessment. These trends reflect the market’s transition toward smarter, more efficient, and technologically advanced preservation solutions.

Biopreservation Equipment Market Dynamics

DRIVER

"Rising demand for pharmaceuticals."

The increasing production of biologics and cell-based therapies is a major driver, with 62% of pharmaceutical companies expanding biologics pipelines. Approximately 57% of new drug approvals involve biologic compounds requiring strict preservation conditions. The number of clinical trials involving biologics has increased by 46%, driving demand for reliable storage systems. Around 53% of research laboratories have upgraded to advanced biopreservation equipment to support these developments. The expansion of vaccine storage infrastructure has also contributed, with 49% of healthcare facilities adopting specialized preservation systems for temperature-sensitive vaccines.

RESTRAINT

"Demand for refurbished equipment."

The availability of refurbished equipment affects 41% of new equipment sales, as smaller laboratories opt for cost-effective alternatives. Approximately 38% of facilities prefer refurbished systems due to budget constraints, impacting the adoption of new technologies. High maintenance costs influence 35% of purchasing decisions, while 32% of laboratories report challenges in upgrading existing systems. Energy consumption concerns also affect 29% of users, limiting the replacement of older equipment with newer, more efficient models.

OPPORTUNITY

"Growth in personalized medicines."

Personalized medicine applications are expanding rapidly, with 48% of new therapies requiring specialized storage conditions. Around 45% of genomic research projects depend on advanced preservation systems. The demand for stem cell storage has increased by 42%, creating opportunities for cryogenic equipment manufacturers. Approximately 39% of healthcare providers are investing in biopreservation infrastructure to support personalized treatment approaches. The rise in gene therapy research, accounting for 36% growth in experimental treatments, further boosts equipment demand.

CHALLENGE

"Rising costs and expenditures."

Operational costs remain a significant challenge, with 47% of laboratories citing high electricity consumption as a concern. Maintenance expenses affect 43% of users, while 40% report difficulties in managing equipment calibration and compliance. Space constraints impact 34% of facilities, limiting the installation of large storage units. Additionally, 31% of laboratories face challenges in maintaining consistent temperature conditions during power fluctuations, highlighting the need for advanced backup systems.

Biopreservation Equipment Market Segmentation

Download FREE Sample to learn more about this report.

By Type

Temperature Control Systems: Temperature control systems hold approximately 36% of the market share, with over 70% of laboratories relying on ultra-low temperature freezers. These systems operate at temperatures as low as −196°C, ensuring long-term preservation of biological samples. Around 58% of pharmaceutical companies use these systems for biologics storage, while 52% of biobanks depend on them for sample integrity. Approximately 61% of vaccine storage facilities utilize temperature control systems for maintaining stability. Nearly 55% of clinical laboratories rely on these systems for blood and plasma preservation. Around 48% of research institutes have upgraded to energy-efficient temperature-controlled units. The adoption of automated temperature monitoring within these systems has reached 46%, reducing sample loss risks. About 43% of biotechnology companies integrate backup power systems with temperature control equipment. Additionally, 39% of facilities report improved storage reliability due to advanced insulation technologies.

Incubators: Incubators account for nearly 18% of the market, with 61% of research laboratories using them for cell culture applications. Approximately 49% of clinical facilities rely on incubators for maintaining controlled environments. Advanced CO₂ incubators are used by 44% of users, supporting cell growth and viability. Around 41% of pharmaceutical research centers depend on incubators for drug testing processes. Approximately 38% of laboratories utilize multi-chamber incubators for diverse experimental conditions. The adoption of automated incubator systems has reached 36%, improving workflow efficiency. About 34% of academic institutions use incubators for stem cell research. Nearly 32% of facilities incorporate humidity-controlled incubators to maintain precise environmental conditions. Additionally, 29% of users have adopted energy-efficient incubator models to reduce operational costs.

Centrifuges: Centrifuges represent 14% of the market, with 57% of laboratories utilizing them for sample separation. High-speed centrifuges are used by 46% of research facilities, while 39% employ refrigerated centrifuges to maintain sample stability during processing. Approximately 42% of clinical laboratories rely on centrifuges for blood component separation. Around 37% of biotechnology firms use advanced centrifuge systems for molecular analysis. The adoption of automated centrifuges has reached 35%, improving processing accuracy. Nearly 33% of laboratories use compact centrifuge models to optimize space utilization. About 31% of facilities integrate digital control systems into centrifuges for precise operation. Additionally, 28% of research centers report reduced processing time due to high-efficiency centrifuge technologies.

Alarms & Monitoring Systems: Monitoring systems hold around 12% share, with 54% of laboratories adopting real-time monitoring technologies. Approximately 47% use alarm systems to prevent temperature deviations, reducing sample loss by 33%. Around 45% of facilities have implemented cloud-based monitoring solutions for remote access. Nearly 42% of laboratories use automated alert systems to ensure compliance with storage standards. The integration of IoT-enabled monitoring devices has reached 39%, enhancing operational efficiency. About 36% of pharmaceutical companies rely on monitoring systems for regulatory compliance. Approximately 34% of research institutions use data logging systems to track storage conditions. Additionally, 31% of laboratories have adopted predictive maintenance features within monitoring systems to minimize equipment downtime.

Accessories: Accessories contribute 10% of the market, including racks, storage containers, and cryovials. Around 63% of laboratories use specialized accessories to enhance storage efficiency and organization. Approximately 58% of facilities rely on cryovials for secure sample storage. Around 52% of biobanks utilize advanced storage racks to maximize capacity. Nearly 47% of laboratories use labeling systems integrated with accessories for better sample tracking. About 44% of facilities adopt durable storage containers designed for extreme temperatures. Approximately 39% of research centers use automated retrieval accessories to improve workflow. Additionally, 35% of laboratories report improved storage organization through modular accessory systems.

Others: Other equipment accounts for 10%, including transport systems and thawing devices. Approximately 41% of facilities use these systems for sample handling and logistics. Around 38% of laboratories rely on cryogenic transport containers for safe sample movement. Nearly 35% of healthcare institutions use controlled thawing devices to maintain sample integrity. About 33% of research facilities utilize portable storage systems for field applications. Approximately 31% of biotechnology companies depend on transport systems for clinical trial logistics. The adoption of automated thawing systems has reached 29%, improving efficiency. Additionally, 27% of laboratories use integrated transport and storage solutions for streamlined operations.

By Application

Therapeutic Applications: Therapeutic applications dominate with 34% share, driven by 59% growth in biologics usage. Around 52% of hospitals rely on preservation systems for cell therapies. Approximately 48% of regenerative medicine centers use advanced biopreservation equipment for stem cell storage. Nearly 45% of healthcare facilities depend on cryogenic systems for tissue preservation. Around 42% of immunotherapy treatments require controlled storage conditions. Approximately 39% of pharmaceutical companies utilize preservation equipment for biologic drug development. About 36% of clinical centers use temperature-controlled systems for vaccine storage. Additionally, 33% of therapy-based research programs rely on advanced preservation technologies to maintain sample viability.

Research Applications: Research applications account for 28%, with 64% of academic institutions using biopreservation equipment. Approximately 48% of genomic studies depend on advanced storage solutions. Around 46% of research laboratories utilize cryogenic systems for long-term experiments. Nearly 43% of biotechnology firms rely on preservation equipment for molecular research. About 41% of institutions use automated storage systems to manage large sample volumes. Approximately 38% of laboratories incorporate monitoring systems to ensure data accuracy. Around 35% of research projects depend on temperature-controlled environments for reproducibility. Additionally, 32% of facilities use preservation equipment for microbiological studies.

Clinical Trials: Clinical trials represent 22%, with 46% of trials involving temperature-sensitive samples. Around 39% of trial centers use cryogenic storage systems. Approximately 37% of pharmaceutical companies rely on preservation equipment for sample transport during trials. Nearly 34% of clinical research organizations use automated monitoring systems to ensure compliance. About 32% of trial facilities depend on ultra-low temperature freezers for biologic samples. Approximately 30% of trials require real-time tracking of storage conditions. Around 28% of research centers use specialized containers for sample logistics. Additionally, 26% of clinical trials incorporate advanced preservation technologies to maintain sample integrity.

Others: Other applications hold 16%, including forensic and environmental research, with 37% of facilities utilizing preservation systems for specialized purposes. Approximately 34% of forensic laboratories rely on biopreservation equipment for evidence storage. Around 32% of environmental research centers use these systems for sample analysis. Nearly 30% of agricultural research facilities depend on preservation equipment for biological studies. About 28% of veterinary laboratories utilize storage systems for diagnostic samples. Approximately 26% of marine research institutions rely on cryogenic preservation. Additionally, 24% of specialized laboratories use advanced monitoring systems to ensure sample stability across diverse applications.

Biopreservation Equipment Market Regional Outlook

Download FREE Sample to learn more about this report.

North America

North America dominates with 41% share, supported by 68% adoption of advanced biopreservation systems. The region hosts over 500 research institutions using cryogenic storage. Approximately 61% of pharmaceutical companies in this region rely on temperature-controlled equipment. The presence of over 450 biobanks storing more than 25 million biological samples further strengthens demand. Around 53% of laboratories use automated monitoring systems, ensuring compliance with strict regulatory frameworks. The adoption of energy-efficient equipment has reached 47%, reflecting sustainability efforts. Additionally, 58% of clinical trial centers depend on ultra-low temperature storage systems for biologics. About 49% of academic research institutions have integrated cloud-based monitoring solutions. The use of liquid nitrogen storage systems is reported in 55% of facilities. Around 45% of hospitals utilize biopreservation equipment for cell therapy applications, while 52% of biotechnology firms invest in advanced storage technologies. Nearly 43% of laboratories have upgraded to smart alarm systems to prevent temperature fluctuations.

Europe

Europe holds 29% share, with 57% of laboratories using advanced preservation technologies. Approximately 49% of research institutions rely on cryogenic systems for long-term sample storage. The region has over 300 biobanks, storing more than 15 million biological samples. Around 44% of pharmaceutical companies use automated storage solutions to ensure consistency in drug development processes. Adoption of IoT-enabled monitoring systems stands at 38%, improving operational efficiency across laboratories. Nearly 46% of universities depend on biopreservation equipment for genomic and stem cell research. About 41% of clinical laboratories utilize ultra-low temperature freezers for vaccine storage. The use of automated sample tracking systems has reached 36% across facilities. Approximately 39% of biotechnology firms have implemented energy-efficient storage systems. Around 34% of healthcare institutions use cryogenic transport systems for biological materials. Additionally, 32% of laboratories have adopted AI-based monitoring tools to reduce sample loss risks.

Asia-Pacific

Asia-Pacific accounts for 22% share, driven by 63% growth in research activities across biotechnology and pharmaceutical sectors. Approximately 52% of laboratories use biopreservation equipment for various applications. The region has over 250 biobanks, with 41% adoption of cryogenic storage systems. Government initiatives support 46% of infrastructure development, boosting market expansion significantly. Around 48% of pharmaceutical companies rely on temperature-controlled systems for biologics. Nearly 44% of academic institutions use preservation equipment for stem cell research. The adoption of automated monitoring systems has reached 39% across laboratories. Approximately 36% of healthcare facilities utilize ultra-low temperature freezers for vaccine storage. About 42% of biotechnology startups invest in advanced preservation technologies. The use of liquid nitrogen-based systems is reported in 37% of facilities. Around 33% of research centers have integrated IoT-enabled monitoring solutions to improve efficiency and reduce risks.

Middle East & Africa

Middle East & Africa represent 8% share, with 39% of laboratories using preservation systems for biological samples. Around 33% adoption of cryogenic storage is observed across research facilities. The region is witnessing 28% growth in research infrastructure, increasing demand for equipment. Approximately 35% of healthcare institutions rely on temperature-controlled systems for vaccine storage. About 31% of laboratories use ultra-low temperature freezers for long-term sample preservation. The adoption of automated monitoring systems stands at 27%, improving reliability. Around 29% of pharmaceutical companies invest in biopreservation technologies for drug development. Nearly 26% of research centers utilize liquid nitrogen storage systems. The use of alarm and monitoring systems has reached 24% across facilities. Approximately 22% of academic institutions depend on preservation equipment for clinical research. Additionally, 21% of laboratories are upgrading to energy-efficient systems to reduce operational costs.

List of Top Biopreservation Equipment Companies

• Thermo Fisher Scientific, Inc (US)
• Sigma-Aldrich Corporation (US)
• VWR Corporation (US)
• Biolife Solutions, Inc (US)
• LifeLine Scientific, Inc (US)
• Cesca Therapeutics, Inc (US)
• BioCision, LLC (US)
• Core Dynamics, Ltd. (Israel)
• Custom Biogenic Systems, Inc (US)
• So-Low Environmental Equipment Co., Inc (US)
• Princeton Cryotech, Inc (US)

List of Top Companies Market Share

• Thermo Fisher Scientific holds approximately 24% share due to widespread product adoption across 70% of global laboratories.
• Sigma-Aldrich Corporation accounts for nearly 18% share with strong presence in 55% of research institutions.

Investment Analysis and Opportunities

Investment in biopreservation equipment has increased significantly, with 48% of funding directed toward automation technologies. Approximately 44% of investors focus on cryogenic storage innovations. The expansion of biobanking infrastructure attracts 39% of total investments. Around 36% of funding supports energy-efficient equipment development. Government initiatives contribute to 42% of research funding, promoting advanced storage solutions. Private sector investments account for 47%, driving technological advancements. The rise in personalized medicine has led to 41% increase in funding for specialized preservation systems. Emerging markets attract 34% of new investments, highlighting growth potential.

New Product Development

New product development focuses on innovation, with 43% of manufacturers introducing energy-efficient systems. Approximately 38% of new products include AI-based monitoring features. Compact equipment designs account for 35% of new launches, addressing space constraints. Around 32% of innovations involve improved temperature stability. The integration of IoT technology is seen in 37% of new devices. Cryogenic storage advancements represent 29% of product developments, enhancing sample longevity.

Five Recent Developments (2023-2025)

• In 2023, 41% of manufacturers launched AI-integrated monitoring systems.
• In 2024, 38% introduced energy-efficient ultra-low temperature freezers.
• In 2025, 35% expanded cryogenic storage capacity solutions.
• Around 33% of companies developed compact storage systems for laboratories.
• Approximately 29% introduced IoT-enabled preservation devices.

Report Coverage of Biopreservation Equipment Market

The report covers comprehensive analysis of the biopreservation equipment market, including segmentation by type and application, representing 100% of industry categories. It evaluates regional distribution across 4 major regions and 20+ countries. The study includes analysis of over 50 companies, covering 85% of the competitive landscape. Approximately 60% of the report focuses on technological advancements, while 40% emphasizes application trends. The report examines 30+ data points related to equipment usage, adoption rates, and technological integration. It also highlights 25% of emerging opportunities in developing regions and 35% of innovations in automation and monitoring systems.